NCT04174339 2019-11-22PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric CancerFujian Cancer HospitalPhase NA Unknown20 enrolled
NCT02982486 2017-11-01A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial CarcinomaAssaf-Harofeh Medical CenterPhase 2 Unknown60 enrolled